JN0003

Ridogrel

≥98% (HPLC)

• Synonym(e): 5-[(E)-[3-pyridyl-[3-(trifluoromethyl)phenyl]methylene]amino]oxypentanoic acid, R 68070, R068070
• Empirische Formel (Hill-System): C₁₈H₁₇F₃N₂O₃
• CAS-Nummer: 110140-89-1
• Molekulargewicht: 366.33
• MDL-Nummer: MFCD00873577
• UNSPSC-Code: 12352200
• NACRES: NA.77

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 2 mg/mL, clear
• Lagertemp.: room temp
• SMILES String: O=C(O)CCCCO/N=C(C1=CC=CN=C1)\C2=CC=CC(C(F)(F)F)=C2
• InChI: 1S/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17-
• InChIKey: GLLPUTYLZIKEGF-QJOMJCCJSA-N

Beschreibung

Biochem./physiol. Wirkung

A₂ receptor antagonist

Ridogrel is an orally active, potent and specific combined thromboxane synthase inhibitor and thromboxane A₂ receptor ( thromboxane/prostaglandin endoperoxide receptor) antagonist. Ridogrel is a potent antiplatelet agent.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable